Phase
Condition
Canker Sores
Treatment
Optical Mapping Scope
Proflavine hemisulfate
High Resolution Microendoscope (HRME)
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adult subjects with clinically evident oral lesions such as leukoplakia orerythroplakia, oral potentially malignant disorders (OPMD) such as lichen planus andgraft vs. host disease, pathologic diagnosis of dysplasia, squamous cell carcinoma,or a history of resected oral cancer, are eligible to participate. Patients withprevious treatment including surgery, radiation, chemotherapy or other therapies arealso eligible.
Ability to understand and willingness to sign a written Informed Consent Document (ICD).
Exclusion
Exclusion Criteria:
Known allergy to proflavine or acriflavine.
Age less than 18 years.
Pregnant or nursing females.
Adults unable to consent
Prisoners and other vulnerable populations
Study Design
Study Description
Connect with a study center
M D Anderson Cancer Center
Houston, Texas 77030
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.